Originally published by our sister publication Specialty Pharmacy Continuum
By Heidi Splete
Sepsis remains a concern for people on immunoglobulin (Ig) therapy, especially those receiving infusions at home, but identification of risk factors and patient education can prevent or catch sepsis early, said Ying-Tang Casapao, PharmD, MBA, BCPPS, in a presentation at the IgNS 2024 National Conference, in Washington, D.C.